Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FMT for MDRO Colonization in Renal Transplant Recipients
NCT02922816Phase 1Terminated
- Sponsor
- Emory University
- Start
- Dec 2016
- Primary completion
- Dec 2021
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of fecal microbiome transplant in organism colonization (2 arms), sponsored by Emory University. Primary endpoints: Number of Adverse Events up to 30 weeks and Change in Target MDRO Growth up to 30 weeks. Started Dec 2016; status: terminated.
02
Drugs
fecal microbiome transplant
03
Conditions
organism colonization
Beyond the preview
Go deeper on NCT02922816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02922816.